CBD can be extracted from marijuana or from another strain of the cannabis plant, hemp.
Use of CBD — cannabidiol, the non-psychoactive component in cannabis — has exploded in the last few years. But while it’s marketed as a solution for stress, anxiety, insomnia, and pain, the Food and Drug Administration can’t say it’s safe. NPR health correspondent Allison Aubrey helps parse the science behind a new set of government warnings about CBD. Follow host Maddie Sofia on Twitter @maddie_sofia. Email the show at [email protected]
This episode was produced by Brent Baughman and edited by Viet Le.
HURD: Neither the participants nor the clinician, the clinical team, knew what they were getting or giving.
A new study suggests that a marijuana extract known as CBD can help reduce stress and cravings among people who’ve been addicted to opioids. The study was published today in the American Journal of Psychiatry. NPR’s Allison Aubrey has more on what impact these findings could have.
AUBREY: Cooper says another important point – the CBD used in the study was a high dose, pharmaceutical grade, pure form of the compound.
AUBREY: During the study, that participants watched videos of people using drugs and saw other drug-related images that could trigger cravings and stress. It turned out the people taking the placebo reacted strongly. Their heart rates went up. Their levels of the stress hormone cortisol increased. And they reported experiencing significant cravings. But the people taking CBD had a different experience.